CLPT insider transaction filings

ClearPoint Neuro, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-03. Screen CLPT transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 7 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
BURNETT JOSEPH — CEO and President, Director31 leg · 20,000 sh · $387,6005
D'Alessandro Danilo — Chief Financial Officer11
FLETCHER R JOHN — Director11
Richards Timothy T. — Director11
STIGALL L. JEREMY — Chief Business Officer11

Recent Form 4 filings — ClearPoint Neuro, Inc.

FiledFormInsiderReported transactionsSource
2026-09-034BURNETT JOSEPH — CEO and President, DirectorOption exercise (M): 12,517 @ $3.47 · Option exercise (M): 12,517 (derivative) @ $0EDGAR
2026-07-064Richards Timothy T. — DirectorGrant/award (A): 222 @ $17.84EDGAR
2026-07-064FLETCHER R JOHN — DirectorGrant/award (A): 662 @ $17.84EDGAR
2026-07-024STIGALL L. JEREMY — Chief Business OfficerGrant/award (A): 1,781 @ $11.93EDGAR
2026-07-024D'Alessandro Danilo — Chief Financial OfficerGrant/award (A): 1,085 @ $11.93EDGAR
2026-07-024BURNETT JOSEPH — CEO and President, DirectorGrant/award (A): 1,361 @ $11.93EDGAR
2026-07-014BURNETT JOSEPH — CEO and President, DirectorOption exercise (M): 20,000 @ $2.50 · Sale (S): 20,000 @ $19.38 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2026-06-224BURNETT JOSEPH — CEO and President, DirectorOption exercise (M): 60,000 @ $2.50 · Sale (S): 60,000 @ $17.79 · Sale (S): 1,843 @ $17.94 · Option exercise (M): 60,000 (derivative) @ $0EDGAR
2026-06-084Richards Timothy T. — DirectorOption exercise (M): 500 @ $10 · Tax withholding (F): 376 @ $13.30 · Option exercise (M): 500 (derivative) @ $10EDGAR
2026-06-024Richards Timothy T. — DirectorSale (S): 5,415 @ $12.17EDGAR
2026-05-264LIAU LINDA M. — DirectorGrant/award (A): 12,820 (derivative) @ $0EDGAR
2026-05-264Richards Timothy T. — DirectorGrant/award (A): 12,820 (derivative) @ $0EDGAR
2026-05-264Klein Matthew B. — DirectorSale (S): 16,000 @ $11.59 · Grant/award (A): 12,820 (derivative) @ $0EDGAR
2026-05-264JOHNSON B KRISTINE — DirectorGrant/award (A): 12,820 (derivative) @ $0EDGAR
2026-05-264FLETCHER R JOHN — DirectorGrant/award (A): 12,820 (derivative) @ $0EDGAR
2026-05-264FALLON LYNNETTE C — DirectorGrant/award (A): 12,820 (derivative) @ $0EDGAR
2026-05-214Klein Matthew B. — DirectorOption exercise (M): 12,417 · Option exercise (M): 12,417 (derivative)EDGAR
2026-05-214Richards Timothy T. — DirectorOption exercise (M): 12,417 · Option exercise (M): 12,417 (derivative)EDGAR
2026-05-214Girin Pascal E R — DirectorOption exercise (M): 12,417 · Option exercise (M): 12,417 (derivative)EDGAR
2026-05-214LIAU LINDA M. — DirectorOption exercise (M): 12,417 · Option exercise (M): 12,417 (derivative)EDGAR
2026-05-214JOHNSON B KRISTINE — DirectorOption exercise (M): 12,417 · Option exercise (M): 12,417 (derivative)EDGAR
2026-05-214FLETCHER R JOHN — DirectorOption exercise (M): 12,417 · Option exercise (M): 12,417 (derivative)EDGAR
2026-05-214FALLON LYNNETTE C — DirectorOption exercise (M): 12,417 · Sale (S): 5,091 @ $11.14 · Option exercise (M): 12,417 (derivative)EDGAR
2026-04-024Girin Pascal E R — DirectorGrant/award (A): 755 @ $9.10EDGAR
2026-04-024Richards Timothy T. — DirectorGrant/award (A): 442 @ $9.10EDGAR
2026-04-024FLETCHER R JOHN — DirectorGrant/award (A): 1,270 @ $9.10EDGAR
2026-03-204BURNETT JOSEPH — CEO and President, DirectorOption exercise (M): 20,942 @ $3.24 · Option exercise (M): 20,942 (derivative) @ $0EDGAR
2026-03-164D'Alessandro Danilo — Chief Financial OfficerOption exercise (M): 32,627 · Tax withholding (F): 16,601 @ $11.53 · Option exercise (M): 32,627 (derivative)EDGAR
2026-03-164BURNETT JOSEPH — CEO and President, DirectorOption exercise (M): 84,829 · Tax withholding (F): 43,161 @ $11.53 · Option exercise (M): 84,829 (derivative)EDGAR
2026-03-164STIGALL L. JEREMY — Chief Business OfficerOption exercise (M): 30,995 · Tax withholding (F): 15,151 @ $11.53 · Option exercise (M): 30,995 (derivative)EDGAR
2026-03-164SABRA MAZIN — Chief Operating OfficerOption exercise (M): 26,101 · Tax withholding (F): 13,281 @ $11.53 · Option exercise (M): 26,101 (derivative)EDGAR
2026-03-134D'Alessandro Danilo — Chief Financial OfficerOption exercise (M): 4,145 · Tax withholding (F): 2,109 @ $11.62 · Option exercise (M): 4,145 (derivative)EDGAR
2026-03-134STIGALL L. JEREMY — Chief Business OfficerOption exercise (M): 8,291 · Tax withholding (F): 3,224 @ $11.62 · Option exercise (M): 8,291 (derivative)EDGAR
2026-03-104BURNETT JOSEPH — CEO and President, DirectorOption exercise (M): 47,407 · Tax withholding (F): 22,709 @ $10 · Option exercise (M): 47,407 (derivative)EDGAR
2026-03-104STIGALL L. JEREMY — Chief Business OfficerOption exercise (M): 17,778 · Tax withholding (F): 6,913 @ $10 · Option exercise (M): 17,778 (derivative)EDGAR
2026-03-104SABRA MAZIN — Chief Operating OfficerOption exercise (M): 13,827 · Tax withholding (F): 7,036 @ $10 · Option exercise (M): 13,827 (derivative)EDGAR
2026-03-104D'Alessandro Danilo — Chief Financial OfficerOption exercise (M): 18,765 · Tax withholding (F): 9,548 @ $10 · Option exercise (M): 18,765 (derivative)EDGAR
2026-03-054BURNETT JOSEPH — CEO and President, DirectorOption exercise (M): 26,568 · Tax withholding (F): 9,533 @ $8.84 · Option exercise (M): 26,568 (derivative)EDGAR
2026-03-054D'Alessandro Danilo — Chief Financial OfficerOption exercise (M): 10,332 · Tax withholding (F): 5,257 @ $8.84 · Option exercise (M): 10,332 (derivative)EDGAR
2026-03-054STIGALL L. JEREMY — Chief Business OfficerOption exercise (M): 8,856 · Tax withholding (F): 4,506 @ $8.84 · Option exercise (M): 8,856 (derivative)EDGAR
2026-03-054SABRA MAZIN — Chief Operating OfficerOption exercise (M): 6,642 · Tax withholding (F): 3,380 @ $8.84 · Option exercise (M): 6,642 (derivative)EDGAR
2026-02-264BURNETT JOSEPH — CEO and President, DirectorSale (S): 19,951 @ $15.17EDGAR
2026-02-194SABRA MAZIN — Chief Operating OfficerGrant/award (A): 36,818 (derivative) @ $0EDGAR
2026-02-194STIGALL L. JEREMY — Chief Business OfficerGrant/award (A): 51,546 (derivative) @ $0EDGAR
2026-02-194D'Alessandro Danilo — Chief Financial OfficerGrant/award (A): 66,273 (derivative) @ $0EDGAR
2026-02-194BURNETT JOSEPH — CEO and President, DirectorGrant/award (A): 147,275 (derivative) @ $0EDGAR
2026-01-274BURNETT JOSEPH — CEO and President, DirectorSale (S): 2,943 @ $15.57EDGAR
2026-01-134BURNETT JOSEPH — CEO and President, DirectorOption exercise (M): 20,000 @ $2.50 · Sale (S): 20,000 @ $16.12 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2026-01-054Girin Pascal E R — DirectorGrant/award (A): 502 @ $13.68EDGAR
2026-01-054FLETCHER R JOHN — DirectorGrant/award (A): 422 @ $13.68EDGAR

Recent 8-K events — ClearPoint Neuro, Inc.

FiledFormItems reportedSource
2026-08-038-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-178-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-058-K/A9.01 — Financial Statements and ExhibitsEDGAR
2026-01-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-058-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
EDGAR
2025-11-208-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-068-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-068-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CLPT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →